Open access
Open access
Powered by Google Translator Translator

Daily Archives: May 3, 2020

Characteristics of 100 Children with Covid-19

3 May, 2020 | 22:29h | UTC

Children with Covid-19 in Pediatric Emergency Departments in Italy – New England Journal of Medicine

Related Systematic Review: SARS-CoV-2 Infection in Children and Adolescents (study and commentaries)

 


New NICE Coronavirus Rapid Guidelines

3 May, 2020 | 22:46h | UTC

See Previous NICE Coronavirus Guidelines: Rapid guidelines and evidence summaries – National Institute for Health and Care Excellence

 


Consensus Document: Restarting Planned Surgery in the Context of the COVID-19 Pandemic

3 May, 2020 | 22:43h | UTC

Restarting planned surgery in the context of the COVID-19 pandemic: A strategy document from the Royal College of Anaesthetists, Association of Anaesthetists, Intensive Care Society and Faculty of Intensive Care Medicine

Related: New Scoring System to Prioritize Medically Necessary Operations (report and commentary)

 


Report: The Future of the COVID-19 Pandemic – Lessons Learned from Pandemic Influenza

3 May, 2020 | 22:36h | UTC

COVID-19: The CIDRAP Viewpoint Part 1: The Future of the COVID-19 Pandemic: Lessons Learned from Pandemic Influenza – Center for Infectious Disease Research and Policy

News Release: COVID-19: The CIDRAP Viewpoint

Commentary: Three potential futures for Covid-19: recurring small outbreaks, a monster wave, or a persistent crisis – STAT

 


New Observational Studies Confirm the Safety of Renin–Angiotensin–Aldosterone System Blockers in Patients with Covid-19

3 May, 2020 | 22:32h | UTC

Editorial: Inhibitors of the Renin–Angiotensin–Aldosterone System and Covid-19 – New England Journal of Medicine

Study 1: Renin–Angiotensin–Aldosterone System Blockers and the Risk of Covid-19 – New England Journal of Medicine

Study 2: Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Covid-19 – New England Journal of Medicine

Study 3: Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19 – New England Journal of Medicine

Study 4: Effects Of ARBs And ACEIs On Virus Infection, Inflammatory Status And Clinical Outcomes In COVID-19 Patients With Hypertension: A Single Center Retrospective Study – Hypertension

Commentary: Blood Pressure Drugs Don’t Increase Coronavirus Risk, Studies Find – The New York Times

See also: Observational Study: Renin-Angiotensin System Inhibitors are Not Associated with Severity or Mortality in Hospitalized Patients with Coronavirus Disease (2 other studies on the subject)

 


Cohort Study: Respiratory Pathophysiology of Mechanically Ventilated Patients with COVID-19

3 May, 2020 | 22:25h | UTC

Respiratory Pathophysiology of Mechanically Ventilated Patients with COVID-19: A Cohort Study – American Journal of Respiratory and Critical Care Medicine

Commentary: PulmCrit – Is COVID-19 ARDS, pseudoARDS, L, or H? Physiology data from Boston – PulmCrit

 

Related Commentary on Twitter

 


Public Health Measures and the Reproduction Number of SARS-CoV-2

3 May, 2020 | 22:23h | UTC

Public Health Measures and the Reproduction Number of SARS-CoV-2 – JAMA

Related Editorial: Public Health Interventions for COVID-19: Emerging Evidence and Implications for an Evolving Public Health Crisis – JAMA

 


Case Series: Characteristics of Ischemic Stroke Associated with COVID-19

3 May, 2020 | 22:18h | UTC

Characteristics of ischaemic stroke associated with COVID-19 – Journal of Neurology, Neurosurgery, and Psychiatry

Commentary: Expert reaction to study looking at COVID-19, ischaemic stroke and blood clots – Science media Centre

Related: Large-Vessel Stroke as a Presenting Feature of Covid-19 in the Young – New England Journal of Medicine AND Coronavirus’s new mystery: It’s causing strokes in healthy people – Vox AND What’s Behind the Sharp Increase in Large-Vessel Stroke Risk in Young, Healthy COVID-19 Patients? – Neurology Today

 


Guideline: Treatment of Patients with Nonsevere and Severe Coronavirus Disease 2019

3 May, 2020 | 22:10h | UTC

Treatment of patients with nonsevere and severe coronavirus disease 2019: an evidence-based guideline – Canadian Medical Association Journal

 


Preprint Study Estimates at 10-11 Years That Each of Those Dying of Covid-19 Have Lost

3 May, 2020 | 22:21h | UTC

COVID-19 – exploring the implications of long-term condition type and extent of multimorbidity on years of life lost: a modelling study – Wellcome Open Research (via @EricTopol see Tweet – Thread)

Commentary: Coronavirus deaths ‘result in more than 10 years of life lost per person’ – Express & Star

 


Short Review: Coagulopathy Associated with COVID-19

3 May, 2020 | 22:09h | UTC

Coagulopathy associated with COVID-19 – Canadian Medical Association Journal

 


Case Series: QT Intervals in Patients with COVID-19 Treated with Hydroxychloroquine Alone or in Combination with Azithromycin

3 May, 2020 | 22:01h | UTC

Assessment of QT Intervals in a Case Series of Patients With Coronavirus Disease 2019 (COVID-19) Infection Treated With Hydroxychloroquine Alone or in Combination With Azithromycin in an Intensive Care Unit – JAMA Cardiology

Commentary: Beth Israel Deaconess Medical Center – Beth Israel Deaconess Medical Center

Related Studies: The Effect of Chloroquine, Hydroxychloroquine and Azithromycin on the Corrected QT Interval in Patients with SARS-CoV-2 Infection – Circulation: Arrhythmia and Electrophysiology (link to abstract – $ for full-text) AND [Preprint] QT Interval Prolongation and Torsade De Pointes in Patients with COVID-19 treated with Hydroxychloroquine/Azithromycin – medRxiv

 


Offline: A Global Health Crisis? No, Something far Worse

3 May, 2020 | 21:58h | UTC

Offline: A global health crisis? No, something far worse – The Lancet

 


FDA Issues Emergency Use Authorization for the Use of Remdesivir to Treat COVID-19

3 May, 2020 | 22:03h | UTC

Coronavirus (COVID-19) Update: FDA Issues Emergency Use Authorization for Potential COVID-19 Treatment – U.S. Food & Drug Administration

Commentary: Expert reaction to news the FDA has provided Emergency Use Authorisation of the drug remdesivir for hospitalised patients with COVID-19 – Science Media Centre

See also: Remdesivir: A Non-Antiviral Antiviral Drug? – Forbes

 


Drive-Through Testing for SARS-CoV-2

3 May, 2020 | 21:54h | UTC

Drive-Through Testing: A Unique, Efficient Method of Collecting Large Volume of Specimens During the SARS-CoV-2 (COVID-19) Pandemic – Mayo Clinic Proceedings

 


Opinion: Pregnant Women Should be Given the Opportunity to be Included in Clinical Trials for COVID-19

3 May, 2020 | 21:51h | UTC

Protection by Exclusion: Another Missed Opportunity to Include Pregnant Women in Research During the Coronavirus Disease 2019 (COVID-19) Pandemic – Obstetrics & Gynecology

“We recommend and urge the scientific community and professional societies that, without clear justification for exclusion, pregnant women should be given the opportunity to be included in clinical trials for COVID-19 based on the concepts of justice, equity, autonomy, and informed consent.”

 


SARS-CoV-2 Productively Infects Human Gut Enterocytes

3 May, 2020 | 21:52h | UTC

SARS-CoV-2 productively infects human gut enterocytes – Science

Commentaries: SARS-CoV-2 Infection of Gut Organoids Bolsters Case for Intestinal Transmission – GEN AND Coronavirus SARS-CoV-2 infects cells of the intestine – Hubrecht Institute

 


Randomized Trial: Fluid Response Evaluation in Sepsis Hypotension and Shock

3 May, 2020 | 21:47h | UTC

Fluid Response Evaluation in Sepsis Hypotension and Shock: A Randomized Clinical Trial – Chest

 


[Abstract Only] Meta-Analysis: Prevalence of Harmful Diagnostic Errors in Hospitalized Adults

3 May, 2020 | 21:45h | UTC

Prevalence of harmful diagnostic errors in hospitalised adults: a systematic review and meta-analysis – BMJ Quality & Safety (link to abstract – $ for full-text) (via @brhospitalist)

 

Related Commentary on Twitter

 


Mon May 04 – 10 Stories of The Day!

3 May, 2020 | 22:51h | UTC

 

1 – New NICE Coronavirus Rapid Guidelines

See Previous NICE Coronavirus Guidelines: Rapid guidelines and evidence summaries – National Institute for Health and Care Excellence

 

2 – Restarting planned surgery in the context of the COVID-19 pandemic: A strategy document from the Royal College of Anaesthetists, Association of Anaesthetists, Intensive Care Society and Faculty of Intensive Care Medicine

Related: New Scoring System to Prioritize Medically Necessary Operations (report and commentary)

 

3 – COVID-19: The CIDRAP Viewpoint Part 1: The Future of the COVID-19 Pandemic: Lessons Learned from Pandemic Influenza – Center for Infectious Disease Research and Policy

News Release: COVID-19: The CIDRAP Viewpoint

Commentary: Three potential futures for Covid-19: recurring small outbreaks, a monster wave, or a persistent crisis – STAT

 

4 – New Observational Studies Confirm the Safety of Renin–Angiotensin–Aldosterone System Blockers in Patients with Covid-19

Editorial: Inhibitors of the Renin–Angiotensin–Aldosterone System and Covid-19 – New England Journal of Medicine

Study 1: Renin–Angiotensin–Aldosterone System Blockers and the Risk of Covid-19 – New England Journal of Medicine

Study 2: Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Covid-19 – New England Journal of Medicine

Study 3: Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19 – New England Journal of Medicine

Study 4: Effects Of ARBs And ACEIs On Virus Infection, Inflammatory Status And Clinical Outcomes In COVID-19 Patients With Hypertension: A Single Center Retrospective Study – Hypertension

Commentary: Blood Pressure Drugs Don’t Increase Coronavirus Risk, Studies Find – The New York Times

See also: Observational Study: Renin-Angiotensin System Inhibitors are Not Associated with Severity or Mortality in Hospitalized Patients with Coronavirus Disease (2 other studies on the subject)

 

5 – Children with Covid-19 in Pediatric Emergency Departments in Italy – New England Journal of Medicine

Related Systematic Review: SARS-CoV-2 Infection in Children and Adolescents (study and commentaries)

 

6 – Respiratory Pathophysiology of Mechanically Ventilated Patients with COVID-19: A Cohort Study – American Journal of Respiratory and Critical Care Medicine

Commentary: PulmCrit – Is COVID-19 ARDS, pseudoARDS, L, or H? Physiology data from Boston – PulmCrit

 

7 – Public Health Measures and the Reproduction Number of SARS-CoV-2 – JAMA

Related Editorial: Public Health Interventions for COVID-19: Emerging Evidence and Implications for an Evolving Public Health Crisis – JAMA

 

8 – COVID-19 – exploring the implications of long-term condition type and extent of multimorbidity on years of life lost: a modelling study – Wellcome Open Research (via @EricTopol see Tweet – Thread)

Commentary: Coronavirus deaths ‘result in more than 10 years of life lost per person’ – Express & Star

 

9 – Characteristics of ischaemic stroke associated with COVID-19 – Journal of Neurology, Neurosurgery, and Psychiatry

Commentary: Expert reaction to study looking at COVID-19, ischaemic stroke and blood clots – Science media Centre

Related: Large-Vessel Stroke as a Presenting Feature of Covid-19 in the Young – New England Journal of Medicine AND Coronavirus’s new mystery: It’s causing strokes in healthy people – Vox AND What’s Behind the Sharp Increase in Large-Vessel Stroke Risk in Young, Healthy COVID-19 Patients? – Neurology Today

 

10 – Coronavirus Disease (COVID-19) Updates / 04 May 2020 Edition

04 May 2020 Edition – COVID-19/SARS-CoV-2 Latest Articles, Guidelines, News & Perspectives (several free resources)

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.